{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:15:55Z","timestamp":1783574155460,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ22H160031"],"award-info":[{"award-number":["LQ22H160031"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.hbpd.2024.09.006","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T16:39:20Z","timestamp":1726763960000},"page":"269-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nomogram for prediction of hepatocellular carcinoma recurrence after liver resection"],"prefix":"10.1016","volume":"24","author":[{"given":"Zhi-Jun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ba-Jin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Kun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Feng","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Sen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2024.09.006_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0003","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hep.32542","article-title":"NAFLD-related hepatocellular carcinoma: the growing challenge","volume":"77","author":"Shah","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0004","doi-asserted-by":"crossref","first-page":"m3544","DOI":"10.1136\/bmj.m3544","article-title":"New advances in the diagnosis and management of hepatocellular carcinoma","volume":"371","author":"Yang","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0042-1748924","article-title":"Biomarker development using liquid biopsy in hepatocellular carcinoma","volume":"42","author":"Grinspan","year":"2022","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0006","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejso.2021.09.012","article-title":"Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patients","volume":"48","author":"Beumer","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0007","first-page":"45","article-title":"Prognostic factors and staging systems in hepatocellular carcinoma","volume":"15","author":"Sel\u00e7uk","year":"2017","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0008","doi-asserted-by":"crossref","first-page":"452","DOI":"10.21037\/hbsn-20-480","article-title":"Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights","volume":"9","author":"Xie","year":"2019","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0009","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.3390\/cancers13071673","article-title":"Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications","volume":"13","author":"Vitale","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11894-022-00835-8","article-title":"Models to predict development or recurence of hepatocellular carcinoma (HCC) in patients with advanced hepatic fibrosis","volume":"24","author":"Yilma","year":"2022","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0011","article-title":"ALBI grade: evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma","volume":"3","author":"Demirtas","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.08.067","article-title":"Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma. Review article","volume":"22","author":"Mouchli","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0013","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1080\/15548627.2021.1988357","article-title":"GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions","volume":"18","author":"Brun","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1137025","article-title":"T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing","volume":"14","author":"Chi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0015","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/cancers14040865","article-title":"Novel gene signatures as prognostic biomarkers for predicting the recurrence of hepatocellular carcinoma","volume":"14","author":"Son","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0016","article-title":"A five-gene signature for recurrence prediction of hepatocellular carcinoma patients","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0017","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0018","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/MEG.0000000000001115","article-title":"Recurrence rate and overall survival of operated ruptured hepatocellular carcinomas","volume":"30","author":"Joliat","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0019","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.32585","article-title":"Eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation","volume":"77","author":"Zeng","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0020","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2147\/JHC.S328198","article-title":"Scirrhous hepatocellular carcinoma: systematic review and pooled data analysis of clinical, radiological, and histopathological features","volume":"8","author":"Murtha-Lemekhova","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0021","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/2045-3701-4-50","article-title":"Proliferative ductular reactions correlate with hepatic progenitor cell and predict recurrence in HCC patients after curative resection","volume":"4","author":"Ye","year":"2014","journal-title":"Cell Biosci"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0022","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5582\/bst.2021.01064","article-title":"Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection","volume":"15","author":"Qin","year":"2021","journal-title":"Biosci Trends"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0023","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1245\/s10434-020-08231-0","volume":"27","author":"Huang","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0024","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/ajt.12684","article-title":"Recurrence of hepatocellular carcinoma: importance of mRECIST response to chemoembolization and tumor size","volume":"14","author":"Kim","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0025","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2017.09.016","article-title":"Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine","volume":"68","author":"Fujiwara","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0026","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s12032-014-0970-z","article-title":"Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC","volume":"31","author":"Zhai","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0027","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.31165","article-title":"Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma","volume":"73","author":"Ahn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0028","article-title":"Increased expression of CCN2, epithelial membrane antigen, and fibroblast activation protein in hepatocellular carcinoma with fibrous stroma showing aggressive behavior","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0029","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/1097-0142(19930915)72:6<1859::AID-CNCR2820720612>3.0.CO;2-A","article-title":"The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis","volume":"72","author":"Kitamoto","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0030","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3748\/wjg.v29.i8.1243","article-title":"Predictors of early and late hepatocellular carcinoma recurrence","volume":"29","author":"Nevola","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0031","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/jcmm.16181","article-title":"Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma","volume":"25","author":"Huo","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0032","doi-asserted-by":"crossref","first-page":"8670","DOI":"10.1038\/s41598-022-12518-5","article-title":"A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection","volume":"12","author":"Wang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0033","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.18632\/aging.204898","article-title":"Combining WGCNA and machine learning to construct immune-related EMT patterns to predict HCC prognosis and immune microenvironment","volume":"15","author":"Sun","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0034","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1002\/cam4.5597","article-title":"Role of NCF2 as a potential prognostic factor and immune infiltration indicator in hepatocellular carcinoma","volume":"12","author":"Huang","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0035","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.omtn.2021.11.006","article-title":"Construction of an HCC recurrence model basedon the investigation of immune-related lncRNAs and related mechanisms","volume":"26","author":"Wang","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.hbpd.2024.09.006_bib0036","article-title":"Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"}],"container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387224001188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387224001188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:37:03Z","timestamp":1762547823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387224001188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1499387224001188"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2024.09.006","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nomogram for prediction of hepatocellular carcinoma recurrence after liver resection","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2024.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}